Results from our studies in Ugandan children with severe malaria suggest children with severe malaria other than cerebral malaria may have cognitive sequelae and that the functional areas, degree, and pathogenesis of cognitive impairment may differ by type of severe malaria. African countries plan to switch from quinine to artesunate for treatment of severe malaria because lower mortality has been documented with artesunate treatment. However, the effects of artesunate on neurodevelopment in children with severe malaria are unknown, as quinine has been used in all studies of neurodevelopment in severe malaria to date. Artesunate has effects that may be neuroprotective (e.g., more rapid parasite clearance, fewer seizures, less hypoglycemia than quinine), but high-dose artesunate has been associated with neurotoxicity in some animal studies. We propose to study the pathogenesis of developmental sequelae in the five most common types of severe malaria, in children treated with artesunate. The study's central hypothesis is that different types of severe malaria affect distinct pathogenic pathways leading to specific functional areas and levels of impairment. Our study has two primary aims.
Aim 1 is to establish the areas and level of neurodevelopmental function affected by the five major types of severe malaria in children treated with artesunate. To accomplish this aim, we will compare areas and age-adjusted level of neurologic, developmental, and behavioral impairment in children with severe malaria (cerebral malaria [CM], severe malarial anemia [SMA], repeated seizures, respiratory distress, prostration) treated with artesunate versus healthy children, 12 months after enrollment. Level of impairment in children with CM or SMA will be compared between children in the present (artesunate) and in past (quinine) studies.
Aim 2 is to identify immunologic, metabolic, and nutritional risk factors associated with neurodevelopmental impairment in children with severe malaria who are treated with artesunate. To accomplish this aim, we will compare the presence/level of risk factors in children with severe malaria to the level of neurologic, developmental, and behavioral deficits 12 months after enrollment. We will assess markers of endovascular and central nervous system inflammation, metabolic changes, and micronutrients that are affected by inflammation and associated with developmental impairment. We predict neurodevelopmental impairment will be present in all forms of severe malaria that level of impairment after artesunate treatment will be lower than after quinine treatment, and that specific immunologic, metabolic, and nutritional factors will be associated with risk of impairment. We expect this study will constitute a significant advance in the understanding of malaria-associated developmental impairment, and will provide a basis for interventions to prevent neurodevelopmental impairment in the millions of children who develop severe malaria every year.

Public Health Relevance

Identification of key factors associated with neurodevelopmental or behavioral impairment in severe malaria could lead to interventions that prevent brain injury and the loss of developmental potential in hundreds of thousands of children in sub-Saharan Africa.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS055349-06
Application #
8617630
Study Section
Special Emphasis Panel (ZRG1-BDCN-N (55))
Program Officer
Hirtz, Deborah G
Project Start
2006-04-01
Project End
2018-12-31
Budget Start
2014-01-15
Budget End
2014-12-31
Support Year
6
Fiscal Year
2014
Total Cost
$561,279
Indirect Cost
$121,283
Name
University of Minnesota Twin Cities
Department
Pediatrics
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Idro, Richard; Kakooza-Mwesige, Angelina; Asea, Benjamin et al. (2016) Cerebral malaria is associated with long-term mental health disorders: a cross sectional survey of a long-term cohort. Malar J 15:184
Brand, Nathan R; Opoka, Robert O; Hamre, Karen E S et al. (2016) Differing Causes of Lactic Acidosis and Deep Breathing in Cerebral Malaria and Severe Malarial Anemia May Explain Differences in Acidosis-Related Mortality. PLoS One 11:e0163728
Bangirana, Paul; Opoka, Robert O; Boivin, Michael J et al. (2016) Neurocognitive domains affected by cerebral malaria and severe malarial anemia in children. Learn Individ Differ 46:38-44
Shabani, Estela; Opoka, Robert O; Bangirana, Paul et al. (2016) The endothelial protein C receptor rs867186-GG genotype is associated with increased soluble EPCR and could mediate protection against severe malaria. Sci Rep 6:27084
John, Chandy C; Carabin, Hélène; Montano, Silvia M et al. (2015) Global research priorities for infections that affect the nervous system. Nature 527:S178-86
Hanisch, Benjamin R; Bangirana, Paul; Opoka, Robert O et al. (2015) Thrombocytopenia May Mediate Disease Severity in Plasmodium falciparum Malaria Through Reduced Transforming Growth Factor Beta-1 Regulation of Proinflammatory and Anti-inflammatory Cytokines. Pediatr Infect Dis J 34:783-8
Shabani, Estela; Opoka, Robert O; Idro, Richard et al. (2015) High plasma erythropoietin levels are associated with prolonged coma duration and increased mortality in children with cerebral malaria. Clin Infect Dis 60:27-35
Cusick, Sarah E; Opoka, Robert O; Lund, Troy C et al. (2014) Vitamin D insufficiency is common in Ugandan children and is associated with severe malaria. PLoS One 9:e113185
Bangirana, Paul; Opoka, Robert O; Boivin, Michael J et al. (2014) Severe malarial anemia is associated with long-term neurocognitive impairment. Clin Infect Dis 59:336-44
Bangirana, Paul; Menk, Jeremiah; John, Chandy C et al. (2013) The association between cognition and academic performance in Ugandan children surviving malaria with neurological involvement. PLoS One 8:e55653

Showing the most recent 10 out of 21 publications